Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis
Clinical trial NCT02866903 · UNKNOWN
Trial details
- NCT number
- NCT02866903
- Sponsor
- Hospices Civils de Lyon
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-18
- Primary completion
- 2019-03-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.